Arndt Vogel (@arndtvogel) 's Twitter Profile
Arndt Vogel

@arndtvogel

Clinician-scientist, focused on liver cancer & precision oncology, Toronto General Hospital/Princess Margaret Cancer Center 🇨🇦/MHH🇩🇪

ID: 1211086357

calendar_today23-02-2013 08:40:33

1,1K Tweet

6,6K Followers

440 Following

Arndt Vogel (@arndtvogel) 's Twitter Profile Photo
Arndt Vogel
@arndtvogel

6 months ago

Trastuzumab deruxtecan in solid tumours with activating HER2 mutations The Lancet Oncology doi.org/10.1016/S1470-… 🔎DESTINY-PanTumor01, 100 pts, 20% Biliary 👉ORR 29·4%, mPFS 4.5 mo, mOS 10.0 mo 🧐Activity "encouraging", but we need additional biomarker ESMO - Eur. Oncology EASL Education ILCA

Trastuzumab deruxtecan in solid tumours with activating HER2 mutations <a href="/TheLancetOncol/">The Lancet Oncology</a> doi.org/10.1016/S1470-… 🔎DESTINY-PanTumor01, 100 pts, 20% Biliary 👉ORR 29·4%, mPFS 4.5 mo, mOS 10.0 mo 🧐Activity "encouraging", but we need additional biomarker <a href="/myESMO/">ESMO - Eur. Oncology</a> <a href="/EASLedu/">EASL Education</a> <a href="/ILCAnews/">ILCA</a>